Contributes reviews on supplier material. Based in Graz.
member · joined 11 Feb 2025
Overview — page 2 of 4
comment on [Meta] the dual agonist rule is doing its job and people should stop complaining in c/survodutide · 12 points · 3 months ago
glucagon co-agonism has a different safety story
comment on [Meta] the dual agonist rule is doing its job and people should stop complaining in c/survodutide · 0 points · 3 months ago
the safety profile is not just tirzepatide amplified
comment on [Meta] the dual agonist rule is doing its job and people should stop complaining in c/survodutide · 7 points · 3 months ago
rodent dual agonist is investigation only
Been lurking in c/dosinglogs for about 15 months and finally have something worth posting. Short version: week 62, 1.7mg, and glucagon is the bit I still cannot get a…
comment on interval stretching is the most under-discussed thing in c/compounding in c/tapering · 30 points · 4 months ago
the regain is treatment of chronic condition ending, not failure
comment on interval stretching is the most under-discussed thing in c/compounding in c/tapering · 4 points · 4 months ago
the 7 week discontinuation arm is the data
comment on small win: A1c stopped being a problem at week 50 in c/t2dglp1 · 6 points · 5 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on week 56 check-in — 26kg down, fatigue manageable, one thing confusing me in c/tapering · 54 points · 5 months ago
no shaming people who restart
comment on tried carrier for 22 weeks. here is what happened. in c/intlshipping · 26 points · 5 months ago
DHL is faster but transit time, EMS is slower but cheaper
comment on [Question] the UK — has anyone got a straight answer on chargeback in c/cryptopay · 24 points · 6 months ago
escrow for group buys is standard, use it
comment on three years of escrow threads, summarised so you do not have to read them in c/cryptopay · 36 points · 6 months ago
Strongly agree.
Yes, exactly this, and it is the bit that took me 79 weeks to accept.
comment on why does nobody talk about regain in c/tapering · 14 points · 6 months ago
STEP 1 and SURMOUNT-4 discontinuation arms show regain
comment on [Meta] proposal — a flair for hypoglycaemia posts in c/t2dglp1 · 5 points · 6 months ago
the 88 A1c trend is the answer
comment on [Discussion] the MASH advice in here is 3 years out of date in c/survodutide · 2 points · 7 months ago
MASH claims need the trial and the biopsy endpoint
comment on someone explain regain to me like I have not read a paper in years in c/tapering · 130 points · 7 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on unpopular opinion: DHL is massively overrated in c/intlshipping · 282 points · 7 months ago
transit time variance is the story, not the average
comment on dual agonist — my 21-week log, condensed into one table in c/survodutide · 1 points · 7 months ago
phase 22 data is interesting, phase 16 will be different
comment on discontinuation: what the trials say vs what this community says in c/tapering · 78 points · 9 months ago
comment on [Question] how do you actually verify crypto in c/cryptopay · 4 points · 9 months ago
chargeback rights are crypto: zero
Adding to this: chargeback is doing more work than the comment implies.
comment on the CGM question that gets asked weekly, answered properly in c/t2dglp1 · 2 points · 9 months ago
Strongly agree. A1c matters as much as weight.
No trophies yet. Most accounts here never get one.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference